In this episode, Alanna Morris, MD, MSc, FACC; Javed Butler, MBBS, FACC; John McMurray, MD, FACC; and Muthiah Vaduganathan, MD, FACC, discuss the role of sodium-glucose transport protein 2 inhibitors in the new hope in heart failure (HF). Visit the Clinical Spotlight Series: Shining a Light on New HF Pharmacotherapies online course page for more information and resources. Educational Support provided by AstraZeneca, Cytokinetics, Merck Sharp & Dohme Corp., and Novartis Pharmaceuticals Corporation.

In this episode, Kim Eagle, MD, MACC, asks Matthew Martinez, MD, FACC, and Steve Ommen, MD, FACC, all of the questions you wish you could ask about hypertrophic cardiomyopathy and the new ACC guidelines. 

In this episode, Frederick Ruberg, MD, and Mathew Maurer, MD, discuss key topics in cardiac amyloidosis such as the evolving understanding of the epidemiology of the disease, contemporary approaches to diagnosis with an emphasis on noninvasive means, disease course and management of heart failure and conduction disease, as well as the recently approved therapeutics for the two major types of cardiac amyloidosis: light-chain and transthyretin. (Educational grant support is provided by Janssen Oncology.)

In this episode, JoAnn Lindenfeld, MD, FACC; Vinay Badhwar, MD, FACC; Sammy Elmariah, MD, MPH, FACC; and Rebecca T. Hahn, MD, FACC, discuss the 2020 Expert Consensus Decision Pathway for mitral regurgitation.

In this episode, Michael Mack, MD, MACC, Kim Eagle, MD, MACC, and Rebecca Hahn, MD, FACC, discuss important changes in the 2020 valvular guideline update.

In this episode, Paul Grayburn, MD, FACC, and Rebecca Hahn, MD, FACC, discuss the five key elements of a comprehensive mitral regurgitation echocardiogram: etiology/morphology, severity, left ventricular size and function, left atrial size and pulmonary artery pressure estimate, and anatomic suitability for intervention.

In this episode, Scott Solomon, Ankeet Bhatt, and Orly Vardeny are joined by William Schaffner to discuss the importance of influenza vaccination particularly this year in the midst of the coronavirus disease 2019 pandemic.

In this episode, Scott Solomon, Ankeet Bhatt, Orly Vardeny, Mohammad Madjid, and Jay Udell take a step back to dive deeper into the mechanisms behind the association between influenza and acute cardiovascular events. Visit the Taking the Lead: Flu and Cardiovascular Disease hub for more information and resources.

In this episode, Scott Solomon, Ankeet Bhatt, and Orly Vardeny discuss the intersection of influenza and cardiology and why cardiovascular practitioners should be concerned about influenza, particularly in the era of coronavirus disease 2019. Visit the Taking the Lead: Flu and Cardiovascular Disease hub for more information and resources.

In this episode, Christopher Granger is joined by endocrinologist Jennifer Green to discuss the main features from the recently published 2020 Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes and how to apply the key points from this document in your practice.

Visit the CVRiD: Applying Emerging Science to Practice Hub to listen to the other episodes in the series and to access other educational content.